Brivaracetam as add-on Treatment of Unverricht-Lundborg Disease (ULD) in Adolescents and Adults

NCT00368251 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

56

Enrollment

INDUSTRY

Sponsor class

Conditions

Unverricht-Lundborg Disease

Interventions

OTHER: Placebo
DRUG: BRV 2.5 mg
DRUG: BRV 25 mg
DRUG: BRV 50 mg

Sponsor

UCB Pharma